Review

The Presenilins in Alzheimer's Disease--Proteolysis Holds the Key

Science  29 Oct 1999:
Vol. 286, Issue 5441, pp. 916-919
DOI: 10.1126/science.286.5441.916

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

Alzheimer's disease (AD) research has shown that patients with an inherited form of the disease carry mutations in the presenilin proteins or the amyloid precursor protein (APP). These disease-linked mutations result in increased production of the longer form of amyloid-β (the primary component of the amyloid deposits found in AD brains). However, it is not clear how the presenilins contribute to this increase. New findings now show that the presenilins affect APP processing through their effects on γ-secretase, an enzyme that cleaves APP. Also, it is known that the presenilins are involved in the cleavage of the Notch receptor, hinting that they either directly regulate γ-secretase activity or themselves are protease enzymes. These findings suggest that the presenilins may prove to be valuable molecular targets for the development of drugs to combat AD.

  • * Correspondence may be sent to either author. E-mail: chaass{at}pbm.med.uni-muenchen.de, Bart.Destrooper{at}med.kuleuven.ac.be

View Full Text

Cited By...